Cadmium Alters the Biotransformation of Carcinogenic Aromatic Amines by Arylamine N -Acetyltransferase Xenobiotic-Metabolizing Enzymes: Molecular, Cellular, and in Vivo Studies
Author(s) -
Nilusha Ragunathan,
Julien Dairou,
Elodie Sanfins,
Florent Busi,
Christophe Noll,
Nathalie Janel,
JeanMarie Dupret,
Fernando RodriguesLima
Publication year - 2010
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.1289/ehp.1002334
Subject(s) - carcinogen , chemistry , biotransformation , xenobiotic , enzyme , arylamine n acetyltransferase , in vivo , biochemistry , toxicokinetics , acetylation , metabolism , biology , microbiology and biotechnology , gene
Cadmium (Cd) is a carcinogenic heavy metal of environmental concern. Exposure to both Cd and carcinogenic organic compounds, such as polycyclic aromatic hydrocarbons or aromatic amines (AAs), is a common environmental problem. Human arylamine N-acetyltransferases (NATs) are xenobiotic-metabolizing enzymes that play a key role in the biotransformation of AA carcinogens. Changes in NAT activity have long been associated with variations in susceptibility to different cancers in relation with exposure to certain AAs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom